Back
Biogen Stock Predictions
Sponsored
BIIB
Sponsored
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
33
BIIB
Biogen
Last Price:
$140.51
Seasonality Move:
-3.18%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]Biogen Stock Forecast
-
Over the next 52 weeks, Biogen has on average historically risen by 39.4% based on the past 33 years of stock performance.
-
Biogen has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Biogen Stock Undervalued?The current Biogen [BIIB] share price is $140.55. The Score for BIIB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Biogen Stock Go Up Next Year?
-
Over the next 52 weeks, Biogen has on average historically risen by 39.4% based on the past 33 years of stock performance.
Biogen Stock Rating
Sell
33
Biogen (BIIB)
is a Sell
Is Biogen overpriced?
-
Biogen has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Biogen Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
252.17
52-Week Low:
140.05
Prediction Charts
Market Cap:
20.5B
Price in USD:
140.55
Volume:
1.1M
Beta:
0.93
Technical Analysis
SMA50:
155.97
SMA100:
174.18
SMA200:
195.47
52-Wk Change:
-42.7%
Stock Predictions
-
Is Biogen stock public?Yes, Biogen is a publicly traded company.
-
What is the Biogen stock quote today?The Biogen stock price is 140.55 USD today.
-
How to buy Biogen stock online?You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-27 | 148.74 | 151.31 | 151.88 | 148.23 |
Dec-30 | 150.92 | 150.19 | 151.18 | 148.19 |
Dec-31 | 150.80 | 152.92 | 153.04 | 150.19 |
Jan-2 | 153.84 | 150.00 | 154.12 | 149.84 |
Jan-3 | 149.73 | 152.21 | 152.97 | 149.73 |
Jan-6 | 151.93 | 153.27 | 153.60 | 151.62 |
Jan-7 | 153.11 | 153.15 | 156.37 | 152.90 |
Jan-8 | 152.27 | 150.75 | 152.82 | 150.07 |
Jan-10 | 149.18 | 148.82 | 150.20 | 147.65 |
Jan-13 | 148.92 | 150.18 | 150.48 | 145.82 |
Jan-14 | 149.92 | 143.06 | 150.22 | 142.42 |
Jan-15 | 145.46 | 141.00 | 146.15 | 140.87 |
Jan-16 | 140.49 | 141.23 | 142.39 | 140.05 |
Jan-17 | 143.13 | 140.55 | 143.50 | 140.06 |
Biogen Earnings
Biogen Earnings Report: Per Share Biogen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen Forecast Revenue Growth
Biogen Stock Analysis: Historical quarterly revenues per share for Biogen and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.84 per share.
* Biogen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.